TraceLink Announces FutureLink Barcelona in June 2019


NORTH READING, Mass., Nov. 1, 2018 /PRNewswire/ -- TraceLink, Inc., the World's Largest Track and Trace Network for connecting the life sciences supply chain and providing real-time information sharing for better patient outcomes, today announced the next FutureLink, to be held June 11-13, 2019 in Barcelona.


Past FutureLink attendees are eligible to receive 50 percent off a full price ticket, if they register before December 31, 2018. 

Taking place after the European Union Falsified Medicines Directive (EU FMD) deadline of February 2019, FutureLink Barcelona will include panels, roundtables and general sessions that will provide actionable insights into utilizing serialization data to deliver significant enterprise benefits, including hands-on education on how to leverage digital information sharing within the TraceLink network.

"In a post-EU FMD world, many businesses will be looking to leverage their serialization investments into long-term operational and commercial value. With a fully digitalized supply chain and an integrated digital supply network, companies will have the capabilities to comply with track and trace compliance, digitalize their various B2B transactions, apply integrated IoT to their business and edge processes, deploy intelligent analytics into their supply chain and engage trading partners, end users and consumers through digital health," said Shabbir Dahod, president and CEO, TraceLink. "FutureLink is the only industry event that brings together the end-to-end supply chain to collaborate on new and innovative digital solutions that maximize the efficacy, quality, safety, security and availability of pharmaceutical products."

To register for FutureLink Barcelona, and learn about past events, please visit:

About TraceLink                                                                                                                                 

TraceLink is the World's Largest Track and Trace Network for connecting the Life Sciences supply chain and eliminating counterfeit prescription drugs from the global marketplace. Leading businesses trust the TraceLink Life Sciences Cloud to deliver complete global connectivity, visibility and traceability of pharmaceuticals from ingredient to patient. A single point and click connection to the Life Sciences Cloud creates a supply chain control tower that delivers the information, insight and collaboration needed to improve performance and reduce risk across global supply, manufacturing and distribution operations. A winner of numerous industry awards including Deloitte's Technology Fast 500 (ranked number 149 in 2016), the Amazon AWS Global Start-Up Challenge Grand Prize, and the Edison Award for Innovation in Health Management, the Life Sciences Cloud is used by businesses across the globe to meet strategic goals in ensuring global compliance, fighting drug counterfeiting, improving on-time and in-full delivery, protecting product quality and reducing operational cost. For more information on TraceLink and our solutions, visit or follow us on LinkedIn, Twitter and Facebook.

TraceLink is funded by Goldman Sachs, FirstMark Capital, Volition Capital and F-Prime Capital.


Cision View original content to download multimedia:

SOURCE TraceLink Inc.


Back to news